Back to Journals » International Journal of Nephrology and Renovascular Disease » Volume 13

Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Expression of Concern]

Authors Hinz M, Stein A, Uncini T

Received 14 April 2020

Accepted for publication 14 April 2020

Published 23 April 2020 Volume 2020:13 Pages 73—74


Hinz M, Stein A, Uncini T. Int J Nephrol Renovasc Dis. 2011;4:101–113.

The Editor-in-Chief and Publisher of International Journal of Nephrology and Renovascular Disease wish to issue an Expression of Concern for the published article.

Concerns have been raised regarding the alleged undisclosed competing interests of some of the authors for the published article. International Journal of Nephrology and Renovascular Disease would like to alert readers of this while our investigation is still ongoing and we will provide an update following the conclusion of our investigation.

The authors have been informed of these concerns and of our investigation. 
Read the original article

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]